Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Staar Surgical Co (STAA) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Staar Surgical Co. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 718937.
Total stock buying since 2014: $70,801,606.
Total stock sales since 2014: $265,644,468.
Total stock option exercises since 2014: $21,908,707.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 2,670,860 | $22,198,634 | 0 | $0 | 79,049 | $138,900 |
| 2024 | 313,861 | $4,409,044 | 0 | $0 | 2,614 | $0 |
| 2023 | 1,760,103 | $31,582,495 | 823 | $51,001 | 123,457 | $515,901 |
| 2022 | 191,075 | $4,530,761 | 158,218 | $10,541,441 | 273,838 | $2,091,412 |
| 2021 | 0 | $0 | 2,705,885 | $209,525,212 | 669,209 | $8,927,779 |
| 2020 | 0 | $0 | 794,276 | $38,451,429 | 543,752 | $9,237,656 |
| 2019 | 100,000 | $1,111,500 | 149,512 | $5,514,272 | 98,773 | $662,317 |
| 2018 | 0 | $0 | 31,810 | $657,924 | 38,331 | $180,793 |
| 2017 | 0 | $0 | 6,000 | $99,917 | 0 | $0 |
| 2016 | 1,562,420 | $4,991,671 | 50,000 | $412,333 | 35,000 | $153,949 |
| 2015 | 541,841 | $1,977,501 | 6,476 | $47,659 | 0 | $0 |
| 2014 | 0 | $0 | 20,000 | $343,280 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-05-28 | Bradsher Neal C | Sale | 217,693 | 73.72 | 16,047,239 |
| 2021-05-27 | Bradsher Neal C | Sale | 47,571 | 71.71 | 3,411,316 |
| 2021-05-24 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Sale | 14,500 | 130.42 | 1,891,089 |
| 2021-05-24 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Option Ex | 14,500 | 16.15 | 234,174 |
| 2021-05-21 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Sale | 15,261 | 126.83 | 1,935,552 |
| 2021-05-21 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Option Ex | 15,261 | 9.30 | 141,927 |
| 2021-05-19 | Farrell Stephen C (Director) | Option Ex | 5,000 | 5.54 | 27,700 |
| 2021-05-12 | Hansen Graydon C. (Sr. VP, Global Operations) | Sale | 5,531 | 110.74 | 612,502 |
| 2021-05-12 | Hansen Graydon C. (Sr. VP, Global Operations) | Option Ex | 954 | 27.31 | 26,053 |
| 2021-05-11 | Hansen Graydon C. (Sr. VP, Global Operations) | Sale | 11,075 | 111.61 | 1,236,080 |
| 2021-05-11 | Hansen Graydon C. (Sr. VP, Global Operations) | Option Ex | 11,075 | 31.75 | 351,686 |
| 2021-05-11 | Mason Caren L (President & CEO) | Sale | 53,500 | 110.70 | 5,922,450 |
| 2021-05-11 | Mason Caren L (President & CEO) | Option Ex | 53,500 | 7.76 | 415,160 |
| 2021-05-10 | Hayashida Jon K. (VP, Global Clinical, Medical) | Sale | 12,109 | 124.67 | 1,509,689 |
| 2021-05-10 | Hayashida Jon K. (VP, Global Clinical, Medical) | Option Ex | 18,719 | 27.36 | 512,245 |
| 2021-05-10 | Holliday Keith (Chief Technology Officer) | Sale | 8,874 | 125.83 | 1,116,615 |
| 2021-05-10 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Sale | 11,583 | 125.72 | 1,456,214 |
| 2021-05-10 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Option Ex | 11,583 | 7.43 | 86,119 |
| 2021-05-10 | Mason Caren L (President & CEO) | Sale | 53,500 | 119.88 | 6,413,580 |
| 2021-05-10 | Mason Caren L (President & CEO) | Option Ex | 53,500 | 7.76 | 415,160 |
| 2021-04-26 | Bradsher Neal C | Sale | 43,383 | 67.65 | 2,934,859 |
| 2021-04-23 | Bradsher Neal C | Sale | 53,854 | 66.75 | 3,595,023 |
| 2021-04-22 | Bradsher Neal C | Sale | 20,669 | 65.17 | 1,346,998 |
| 2021-03-22 | Hayashida Jon K. (VP, Global Clinical, Medical) | Sale | 1,103 | 96.37 | 106,296 |
| 2021-03-22 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Sale | 922 | 96.37 | 88,853 |
| 2021-03-22 | Gesten Samuel J (Chief Legal Officer) | Sale | 1,032 | 96.37 | 99,453 |
| 2021-03-16 | Barnes Scott D (Chief Medical Officer) | Option Ex | 2,664 | 15.25 | 40,626 |
| 2021-03-12 | Barnes Scott D (Chief Medical Officer) | Option Ex | 2,936 | .00 | 0 |
| 2021-03-12 | Holliday Keith (Chief Technology Officer) | Option Ex | 2,471 | .00 | 0 |
| 2021-03-12 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Option Ex | 2,169 | .00 | 0 |
| 2021-03-12 | Williams Patrick F. (Chief Financial Officer) | Option Ex | 2,513 | .00 | 0 |
| 2021-03-12 | Gesten Samuel J (Chief Legal Officer) | Option Ex | 2,430 | .00 | 0 |
| 2021-03-12 | Mason Caren L (President & CEO) | Option Ex | 19,363 | .00 | 0 |
| 2021-03-11 | Barnes Scott D (Chief Medical Officer) | Option Ex | 2,665 | 15.25 | 40,641 |
| 2021-03-09 | Barnes Scott D (Chief Medical Officer) | Option Ex | 7,333 | 27.31 | 200,264 |
| 2021-03-03 | Mason Caren L (President & CEO) | Sale | 45,000 | 98.32 | 4,424,400 |
| 2021-03-03 | Mason Caren L (President & CEO) | Option Ex | 45,000 | 7.76 | 349,200 |
| 2021-03-02 | Mason Caren L (President & CEO) | Sale | 45,000 | 103.53 | 4,658,850 |
| 2021-03-02 | Mason Caren L (President & CEO) | Option Ex | 45,000 | 7.76 | 349,200 |
| 2021-03-01 | Hansen Graydon C. (Sr. VP, Global Operations) | Sale | 33,790 | 104.10 | 3,517,437 |
| 2021-03-01 | Hansen Graydon C. (Sr. VP, Global Operations) | Option Ex | 26,615 | 24.41 | 649,618 |
| 2021-03-01 | Hayashida Jon K. (VP, Global Clinical, Medical) | Sale | 16,000 | 105.43 | 1,686,880 |
| 2021-03-01 | Hayashida Jon K. (VP, Global Clinical, Medical) | Option Ex | 16,000 | 35.98 | 575,680 |
| 2021-03-01 | Holliday Keith (Chief Technology Officer) | Sale | 18,991 | 104.33 | 1,981,425 |
| 2021-03-01 | Holliday Keith (Chief Technology Officer) | Option Ex | 13,783 | 22.81 | 314,348 |
| 2021-03-01 | Mason Caren L (President & CEO) | Sale | 45,000 | 104.76 | 4,714,200 |
| 2021-03-01 | Mason Caren L (President & CEO) | Option Ex | 45,000 | 7.76 | 349,200 |
| 2021-03-01 | Silverman Lou (Director) | Sale | 23,996 | 104.78 | 2,514,300 |
| 2021-02-12 | Bradsher Neal C | Sale | 22,250 | 62.11 | 1,381,947 |
| 2021-02-11 | Bradsher Neal C | Sale | 7,412 | 62.26 | 461,434 |
| 2021-02-10 | Bradsher Neal C | Sale | 7,789 | 62.45 | 486,423 |
| 2021-02-09 | Bradsher Neal C | Sale | 65,081 | 62.05 | 4,037,950 |
| 2021-02-08 | Bradsher Neal C | Sale | 144,838 | 61.14 | 8,855,395 |
| 2021-02-05 | Bradsher Neal C | Sale | 47,700 | 58.05 | 2,768,746 |
| 2021-02-04 | Bradsher Neal C | Sale | 48,687 | 55.58 | 2,705,780 |
| 2021-02-03 | Bradsher Neal C | Sale | 10,585 | 55.22 | 584,503 |
| 2021-02-02 | Bradsher Neal C | Sale | 1,589 | 55.16 | 87,649 |
| 2021-01-28 | Bradsher Neal C | Sale | 278,197 | 52.91 | 14,720,794 |
| 2021-01-27 | Bradsher Neal C | Sale | 164,686 | 51.99 | 8,562,848 |
| 2021-01-26 | Bradsher Neal C | Sale | 347,000 | 51.16 | 17,754,255 |
| 2021-01-12 | Bradsher Neal C | Sale | 60,000 | 44.64 | 2,678,400 |
| 2020-11-23 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Sale | 18,959 | 80.13 | 1,519,184 |
| 2020-11-23 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Option Ex | 18,959 | 11.45 | 216,985 |
| 2020-11-23 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Sale | 4,774 | 83.08 | 396,623 |
| 2020-11-23 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Option Ex | 1,900 | 15.54 | 29,526 |
| 2020-11-20 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Sale | 2,688 | 83.02 | 223,157 |
| 2020-11-19 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Sale | 14,007 | 82.03 | 1,148,994 |
| 2020-11-19 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Option Ex | 24,312 | 48.78 | 1,185,939 |
| 2020-11-16 | Barnes Scott D (Chief Medical Officer) | Option Ex | 45,186 | 48.68 | 2,199,518 |
| 2020-11-09 | Hayashida Jon K. (VP, Global Clinical, Medical) | Sale | 20,000 | 81.34 | 1,626,800 |
| 2020-11-09 | Hayashida Jon K. (VP, Global Clinical, Medical) | Option Ex | 20,000 | 22.98 | 459,500 |
| 2020-11-09 | Holliday Keith (Chief Technology Officer) | Sale | 23,714 | 81.56 | 1,934,113 |
| 2020-11-09 | Holliday Keith (Chief Technology Officer) | Option Ex | 38,714 | 8.41 | 325,584 |
| 2020-11-09 | Moore John C (Director) | Option Ex | 16,206 | 14.06 | 227,904 |
| 2020-09-15 | Holliday Keith (Chief Technology Officer) | Sale | 36,326 | 53.33 | 1,937,265 |
| 2020-09-15 | Holliday Keith (Chief Technology Officer) | Option Ex | 36,326 | 27.31 | 992,063 |
| 2020-09-14 | Holliday Keith (Chief Technology Officer) | Sale | 35,689 | 53.38 | 1,904,900 |
| 2020-09-14 | Holliday Keith (Chief Technology Officer) | Option Ex | 26,574 | 10.99 | 292,048 |
| 2020-09-09 | Moore John C (Director) | Sale | 137,331 | 52.04 | 7,146,705 |
| 2020-08-10 | Hayashida Jon K. (VP, Global Clinical, Medical) | Sale | 41,602 | 51.22 | 2,130,854 |
| 2020-08-10 | Hayashida Jon K. (VP, Global Clinical, Medical) | Option Ex | 41,602 | 10.40 | 432,785 |
| 2020-06-15 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Sale | 39,215 | 44.07 | 1,728,205 |
| 2020-06-15 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Option Ex | 39,215 | 8.17 | 320,386 |
| 2020-06-10 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Sale | 785 | 44.00 | 34,540 |
| 2020-06-10 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Option Ex | 785 | 11.00 | 8,635 |
| 2020-05-21 | Gesten Samuel J (Chief Legal Officer) | Sale | 192,522 | 40.00 | 7,700,880 |
| 2020-05-15 | Holliday Keith (Chief Technology Officer) | Sale | 25,000 | 37.69 | 942,250 |
| 2020-05-15 | Holliday Keith (Chief Technology Officer) | Option Ex | 25,000 | 7.20 | 180,000 |
| 2020-05-13 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Option Ex | 6,667 | 5.34 | 35,601 |
| 2020-05-11 | Hansen Graydon C. (Sr. VP, Global Operations) | Sale | 18,189 | 39.02 | 709,789 |
| 2020-05-11 | Hansen Graydon C. (Sr. VP, Global Operations) | Option Ex | 20,283 | 13.57 | 275,179 |
| 2020-05-11 | Hayashida Jon K. (VP, Global Clinical, Medical) | Sale | 46,563 | 39.11 | 1,821,078 |
| 2020-05-11 | Hayashida Jon K. (VP, Global Clinical, Medical) | Option Ex | 46,563 | 8.49 | 395,180 |
| 2020-05-11 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Sale | 18,856 | 39.06 | 736,515 |
| 2020-05-11 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Option Ex | 18,856 | 11.45 | 215,806 |
| 2020-03-23 | Hansen Graydon C. (Sr. VP, Global Operations) | Sale | 2,813 | 27.42 | 77,132 |
| 2020-03-23 | Hayashida Jon K. (VP, Global Clinical, Medical) | Sale | 2,813 | 26.83 | 75,472 |
| 2020-03-23 | Francese James E (Sr. VP, Comm. Ops., NA, APAC) | Sale | 2,250 | 26.77 | 60,232 |
| 2020-03-23 | Gesten Samuel J (Chief Legal Officer) | Sale | 2,742 | 27.42 | 75,185 |
| 2020-03-23 | Andrews Deborah J (Chief Financial Officer) | Sale | 834 | 27.42 | 22,868 |
| 2020-03-18 | Moore John C (Director) | Option Ex | 10,000 | 5.81 | 58,099 |
| 2020-01-21 | Andrews Deborah J (Chief Financial Officer) | Sale | 106,604 | 42.20 | 4,498,688 |
| 2020-01-21 | Andrews Deborah J (Chief Financial Officer) | Option Ex | 106,604 | 13.01 | 1,386,918 |
| 2019-12-05 | Hayashida Jon K. (VP, Global Clinical, Medical) | Sale | 47,408 | 37.23 | 1,764,999 |
| 2019-12-05 | Hayashida Jon K. (VP, Global Clinical, Medical) | Option Ex | 32,335 | 8.64 | 279,374 |
| 2019-12-04 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Sale | 45,000 | 38.15 | 1,716,750 |
| 2019-12-04 | Blickensdoerfer Hans-martin (Sr. VP, Comm. Ops, China) | Option Ex | 45,000 | 5.58 | 251,325 |
| 2019-11-22 | Hansen Graydon C. (Sr. VP, Global Operations) | Option Ex | 13,938 | 8.41 | 117,218 |
| 2019-11-20 | Hansen Graydon C. (Sr. VP, Global Operations) | Sale | 17,083 | 35.02 | 598,246 |
| 2019-11-14 | Barnes Scott D (Chief Medical Officer) | Sale | 1,583 | 34.93 | 55,294 |
| 2019-11-14 | Andrews Deborah J (Chief Financial Officer) | Sale | 4,167 | 34.68 | 144,511 |
| 2019-11-05 | Holliday Keith (Chief Technology Officer) | Sale | 14,441 | 35.00 | 505,435 |
| 2019-11-04 | Holliday Keith (Chief Technology Officer) | Sale | 2,100 | 35.00 | 73,500 |
| 2019-05-06 | Moore John C (Director) | Option Ex | 7,500 | 1.92 | 14,400 |
| 2019-05-03 | Bradsher Neal C | Buy | 100,000 | 11.12 | 1,111,500 |
| 2019-04-04 | Andrews Deborah J (Chief Financial Officer) | Sale | 1,000 | 34.35 | 34,350 |
| 2019-03-22 | Holliday Keith (Chief Technology Officer) | Sale | 3,125 | 38.89 | 121,531 |
| 2019-03-22 | Gesten Samuel J (Chief Legal Officer) | Sale | 1,688 | 38.87 | 65,612 |
| 2019-03-22 | Andrews Deborah J (Chief Financial Officer) | Sale | 833 | 38.88 | 32,387 |
| 2019-03-19 | Holliday Keith (Chief Technology Officer) | Sale | 2,084 | 36.22 | 75,482 |
| 2019-03-19 | Gesten Samuel J (Chief Legal Officer) | Sale | 1,500 | 36.20 | 54,300 |
| 2019-03-19 | Mason Caren L (President & CEO) | Sale | 7,500 | 36.25 | 271,875 |
| 2018-08-20 | Wall William P (Director) | Sale | 5,000 | 41.35 | 206,750 |
| 2018-05-07 | Andrews Deborah J (Chief Financial Officer) | Option Ex | 25,000 | 5.68 | 142,000 |
| 2018-05-03 | Andrews Deborah J (Chief Financial Officer) | Sale | 13,331 | 17.60 | 234,625 |
| 2018-05-03 | Andrews Deborah J (Chief Financial Officer) | Option Ex | 13,331 | 2.91 | 38,793 |
| 2018-03-22 | Holliday Keith (Chief Technology Officer) | Sale | 2,188 | 16.03 | 35,064 |
| 2018-03-22 | Gesten Samuel J (Chief Legal Officer) | Sale | 2,833 | 16.05 | 45,469 |
| 2018-03-22 | Andrews Deborah J (Chief Financial Officer) | Sale | 333 | 16.05 | 5,344 |
| 2018-03-20 | Holliday Keith (Chief Technology Officer) | Sale | 1,458 | 16.05 | 23,400 |
| 2018-03-19 | Mason Caren L (President & CEO) | Sale | 6,667 | 16.09 | 107,272 |
| 2017-11-21 | Holliday Keith (V.P., Chief Technology Officer) | Sale | 6,000 | 16.65 | 99,917 |
| 2016-12-09 | Blickensdoerfer Hans-martin (Sr. VP, EMEA, LA and China) | Sale | 4,320 | 11.32 | 48,885 |
| 2016-12-09 | Blickensdoerfer Hans-martin (Sr. VP, EMEA, LA and China) | Option Ex | 4,320 | 5.39 | 23,284 |
| 2016-12-08 | Blickensdoerfer Hans-martin (Sr. VP, EMEA, LA and China) | Sale | 20,680 | 11.10 | 229,589 |
| 2016-12-08 | Blickensdoerfer Hans-martin (Sr. VP, EMEA, LA and China) | Option Ex | 20,680 | 5.39 | 111,465 |
| 2016-06-29 | Bradsher Neal C | Buy | 8,344 | 2.62 | 21,852 |
| 2016-06-28 | Bradsher Neal C | Buy | 5,800 | 2.62 | 15,190 |
| 2016-05-25 | Bradsher Neal C | Buy | 4,704 | 2.56 | 12,042 |
| 2016-05-24 | Moore John C (Director) | Option Ex | 10,000 | 1.92 | 19,200 |
| 2016-05-24 | Bradsher Neal C | Buy | 70,000 | 2.58 | 180,600 |
| 2016-05-23 | Bradsher Neal C | Buy | 3,138 | 2.62 | 8,221 |
| 2016-05-20 | Meier Richard A (Director) | Sale | 8,849 | 5.32 | 47,032 |
| 2016-05-19 | Meier Richard A (Director) | Sale | 16,151 | 5.38 | 86,827 |
| 2016-05-17 | Broadwood Capital Inc | Buy | 9,313 | 2.61 | 24,344 |
| 2016-05-16 | Bradsher Neal C | Buy | 101,644 | 2.57 | 261,225 |
| 2016-05-13 | Bradsher Neal C | Buy | 90,631 | 2.82 | 255,760 |
| 2016-05-12 | Bradsher Neal C | Buy | 143,935 | 2.83 | 406,760 |
| 2016-02-03 | Bradsher Neal C | Buy | 40,000 | 3.19 | 127,520 |
| 2016-02-02 | Bradsher Neal C | Buy | 81,599 | 3.21 | 261,932 |
| 2016-02-01 | Broadwood Capital Inc | Buy | 12,010 | 3.24 | 38,924 |
| 2016-01-29 | Broadwood Capital Inc | Buy | 40,231 | 3.24 | 130,469 |
| 2016-01-28 | Broadwood Capital Inc | Buy | 13,742 | 3.23 | 44,455 |
| 2016-01-27 | Broadwood Capital Inc | Buy | 44,361 | 3.26 | 144,794 |
| 2016-01-26 | Broadwood Capital Inc | Buy | 112,900 | 3.30 | 372,570 |
| 2016-01-25 | Broadwood Capital Inc | Buy | 81,752 | 3.37 | 275,504 |
| 2016-01-20 | Bradsher Neal C | Buy | 39,921 | 3.37 | 134,334 |
| 2016-01-19 | Bradsher Neal C | Buy | 32,937 | 3.38 | 111,458 |
| 2016-01-15 | Broadwood Capital Inc | Buy | 91,734 | 3.35 | 307,584 |
| 2016-01-14 | Broadwood Capital Inc | Buy | 9,491 | 3.40 | 32,221 |
| 2016-01-13 | Broadwood Capital Inc | Buy | 34,500 | 3.39 | 116,817 |
| 2016-01-11 | Bradsher Neal C | Buy | 31,790 | 3.42 | 108,785 |
| 2016-01-08 | Bradsher Neal C | Buy | 54,796 | 3.41 | 186,963 |
| 2016-01-07 | Broadwood Capital Inc | Buy | 240,150 | 3.47 | 832,840 |
| 2016-01-06 | Broadwood Capital Inc | Buy | 4,427 | 3.52 | 15,583 |
| 2016-01-05 | Broadwood Capital Inc | Buy | 22,470 | 3.54 | 79,633 |
| 2016-01-04 | Broadwood Capital Inc | Buy | 136,100 | 3.55 | 483,291 |
| 2015-12-31 | Broadwood Capital Inc | Buy | 18,648 | 3.57 | 66,573 |
| 2015-12-30 | Broadwood Capital Inc | Buy | 10,713 | 3.57 | 38,202 |
| 2015-09-29 | Bradsher Neal C | Buy | 58,724 | 3.56 | 209,292 |
| 2015-09-28 | Bradsher Neal C | Buy | 110,724 | 3.54 | 391,520 |
| 2015-09-25 | Bradsher Neal C | Buy | 141,651 | 3.54 | 501,019 |
| 2015-08-25 | Bradsher Neal C | Buy | 15,504 | 3.62 | 56,124 |
| 2015-08-24 | Mason Caren L (Director) | Buy | 10,000 | 7.34 | 73,420 |
| 2015-08-24 | Bradsher Neal C | Buy | 122,577 | 3.60 | 441,522 |
| 2015-08-21 | Bradsher Neal C | Buy | 50,800 | 3.53 | 179,476 |
| 2015-08-10 | Silverman Lou (Director) | Buy | 1,500 | 8.18 | 12,273 |
| 2015-08-06 | Roush Jack Steven (Director) | Buy | 1,000 | 8.08 | 8,080 |
| 2015-04-06 | Gesten Samuel J (VP, General Counsel) | Sale | 3,223 | 7.14 | 23,015 |
| 2015-03-03 | Hughes Robin (Vice President, R&D) | Sale | 3,253 | 7.58 | 24,644 |
| 2014-03-20 | Hughes Robin (Vice President, R&D) | Sale | 20,000 | 17.16 | 343,280 |
Insider trading activities including stock purchases, stock sales, and option exercises of STAA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Staar Surgical Co (symbol STAA, CIK number 718937) see the Securities and Exchange Commission (SEC) website.